Angiotensin receptors are present in many tissue types, including adre
nal cortex, renal glomeruli, heart, hypothalamus, liver, pancreas, pit
uitary, platelets, renal tubules, uterus and vascular smooth muscle. T
wo high-affinity receptor subtypes have been identified by radioligand
binding with antagonists: losartan (DuP 753/MK954) identifies AT1 rec
eptors; PD123177 and CGP42112A are markers for AT2 receptors. Angioten
sin II may be produced locally in tissues outside the humoral system.
For example, it is found in the brain, kidney and heart. Within the br
ain, the heptapeptide angiotensin(1-7) mimics some effects of angioten
sin II, but may be formed directly from angiotensin I. Evidence for no
n-ACE-mediated angiotensin II production has been reported in the hear
t. Intravascular angiotensin II receptors are implicated in the centra
l release of vasopressin and other hypophyseal hormones, in increasing
sympathetic outflow, in the thirst response and, possibly, in cogniti
ve function; in the inotropic and chronotropic effects of angiotensin
II on the heart as well as in growth/hypertrophy; in the control of al
dosterone release and in the balance between cortisol and aldosterone
secretion; and in modulating sodium, chloride and bicarbonate transpor
t within the kidney. Effects on the reproductive system, liver and pan
creas have not been established. The pharmacological effects of angiot
ensin II antagonists will depend on their distribution characteristics
as well as affinity for specific receptor subtypes. At present, howev
er, the physiological role of AT2 receptors has not been defined.